Matinas BioPharma Inc. (MTNB)
AMEX: MTNB
· Real-Time Price · USD
1.73
-0.01 (-0.57%)
At close: Aug 21, 2025, 3:59 PM
1.70
-1.73%
After-hours: Aug 21, 2025, 07:56 PM EDT
Matinas BioPharma Revenue
Matinas BioPharma reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Matinas BioPharma generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
3
Market Cap
8.8M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 1.1M | -65.62% |
| Dec 31, 2022 | 3.19M | +9464.10% |
| Dec 31, 2021 | 33.33K | -78.95% |
| Dec 31, 2020 | 158.33K | +75.93% |
| Dec 31, 2019 | 90K | -24.84% |
| Dec 31, 2018 | 119.75K | -20.00% |
| Dec 31, 2017 | 149.69K | +Infinity% |
| Dec 31, 2016 | 0 | -100.00% |
| Dec 31, 2015 | 194.49K | +Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |